- Home
- LAB vs INNV Comparison
LAB vs INNV Comparison
Compare LAB & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAB
- INNV
- Stock Information
- Founded
- LAB 1999
- INNV 2007
- Country
- LAB United States
- INNV United States
- Employees
- LAB N/A
- INNV N/A
- Industry
- LAB Biotechnology: Laboratory Analytical Instruments
- INNV Medical/Nursing Services
- Sector
- LAB Industrials
- INNV Health Care
- Exchange
- LAB Nasdaq
- INNV Nasdaq
- Market Cap
- LAB 451.0M
- INNV 373.3M
- IPO Year
- LAB 2011
- INNV 2021
- Fundamental
- Price
- LAB $1.12
- INNV $3.57
- Analyst Decision
- LAB Buy
- INNV Sell
- Analyst Count
- LAB 2
- INNV 2
- Target Price
- LAB $2.50
- INNV $5.00
- AVG Volume (30 Days)
- LAB 999.6K
- INNV 37.8K
- Earning Date
- LAB 05-06-2025
- INNV 05-06-2025
- Dividend Yield
- LAB N/A
- INNV N/A
- EPS Growth
- LAB N/A
- INNV N/A
- EPS
- LAB N/A
- INNV N/A
- Revenue
- LAB $169,687,000.00
- INNV $831,683,000.00
- Revenue This Year
- LAB N/A
- INNV $13.21
- Revenue Next Year
- LAB $12.77
- INNV $10.29
- P/E Ratio
- LAB N/A
- INNV N/A
- Revenue Growth
- LAB 33.86
- INNV 12.19
- 52 Week Low
- LAB $0.95
- INNV $2.60
- 52 Week High
- LAB $2.74
- INNV $6.69
- Technical
- Relative Strength Index (RSI)
- LAB 47.61
- INNV 64.84
- Support Level
- LAB $0.95
- INNV $2.84
- Resistance Level
- LAB $1.21
- INNV $3.18
- Average True Range (ATR)
- LAB 0.10
- INNV 0.26
- MACD
- LAB -0.01
- INNV 0.06
- Stochastic Oscillator
- LAB 43.42
- INNV 96.84
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
About INNV InnovAge Holding Corp.
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.